It was wonderful to catch up with Bryan Ang (Tan Tock Seng Hospital, Novena, Singapore) about the Xen®45 (Allergan Inc., Irvine, CA, USA) and its use in treating open angle glaucoma.
Questions:
- What factors can cause failure of minimally invasive glaucoma surgery (MIGS)? (00:15)
- When should bleb needling be considered during MIGS with the Xen45 gel stent? (01:23)
- What surgical tips would you like to share for the optimal way to perform bleb needling? (01:51)
- What should be considered if the IOP remains suboptimal despite multiple needling attempts? (02:38)
- What other factors should be considered to ensure postoperative success in open revision surgery? (03:35)
Speaker Disclosure: Bryan Ang has received consultant, research, travel, and speakers’ honoraria from Allergan/Abbvie.
Support: Interview and filming supported by Touch Medical Media Ltd. Interview conducted by Lisa Glass.
Filmed in coverage of AAO 2021.
